Status:
COMPLETED
MBC Physical Activity Study
Lead Sponsor:
Thomas Jefferson University
Conditions:
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Eligibility:
FEMALE
18-120 years
Phase:
NA
Brief Summary
This clinical trial evaluates the impact of a tailored physical activity program on physical activity in patients with breast cancer that has spread from where it first started to other places in the ...
Detailed Description
This single-arm study aims to evaluate the impact of participation in a physical rehabilitation program tailored for metastatic breast cancer (MBC) patients on physical activity, quality of life (QOL)...
Eligibility Criteria
Inclusion
- Female
- Aged 18 and older
- Able to read and speak English
- Diagnosed with metastatic breast cancer within 60 months of study enrollment
- Performance status Eastern Cooperative Oncology Group (ECOG) 0-2
- Insufficiently inactive defined as answer "no" to screening question "On average, do you engage in at least 75 minutes a week of vigorous activity (like jogging) or at least 150 minutes a week of moderate activity (like a brisk walk)?"
- Able to comprehend and sign a written informed consent (no cognitive decline)
- Willing to comply with all study procedures and be available for the duration of the study through at least week 2 of 2Unstoppable
- Medically cleared by co-investigator or principal investigator (PI) to engage in aerobic and resistance exercise intervention
- Access to a smart device and have an active wi-fi connection at home
Exclusion
- Severe or unstable cardiopulmonary, metabolic, or renal disease
- Unable to walk safely without physical assistance of another person or assistive device
- Any condition that may limit the ability to comply with behavioral and physical recommendations of the virtual exercise program
- Pregnancy
Key Trial Info
Start Date :
September 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06500858
Start Date
September 6 2024
End Date
October 30 2025
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107